R, F., ME, C., HH, D., & JL, V. (2019). Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: Integrated analysis of two Phase III clinical studies. Dove Medical Press.
Style de citation Chicago (17e éd.)R, Fong, Cavet ME, DeCory HH, et Vittitow JL. Loteprednol Etabonate (submicron) Ophthalmic Gel 0.38% Dosed Three Times Daily Following Cataract Surgery: Integrated Analysis of Two Phase III Clinical Studies. Dove Medical Press, 2019.
Style de citation MLA (8e éd.)R, Fong, et al. Loteprednol Etabonate (submicron) Ophthalmic Gel 0.38% Dosed Three Times Daily Following Cataract Surgery: Integrated Analysis of Two Phase III Clinical Studies. Dove Medical Press, 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.